Multidisciplinary Return-to-work Rehabilitation and Return-to Work Follow-up
Multidisciplinary Return-to-work Rehabilitation and Return-to-work Follow-up, a Randomized Study of Patients With Complex Symptom Disorders
The large number of people on long-term sick leave is a major public health concern in Norway. The main causes of disability are musculoskeletal and mental disorders. Long-term sick leave causes a decline in individual life-quality, is associated with increased risk for mental disorders and represents a very large cost for the Norwegian society.
The purpose of this study is to determine whether the patients included return to work after rehabilitation at Hysnes Rehabilitation Centre. This includes an investigation of what is considered to be the effect of Return-to-work rehabilitation measured before, during and after the stay at the rehabilitation centre:
The study specifically looks at the effect of structured and standardized return-to-work follow up of the patient, including contact with stakeholders (general practitioner, social security office and workplace).
In addition there is a need to describe the patients participating in the program. The aetiology of complex symptom disorders is poorly understood and the role of genetics and stress is not translatable to a complex symptom population. This complicates the transition from current biological research to a clinical use regarding these patients. If the investigators can assist in understanding how these patients, who are multiusers of health care and have received sickness benefit for a long time, develop their disorders and symptoms, it will be of great importance to the Norwegian community. Therefore the study consists of multimodal measurements of the patients before, during and after a rehabilitation programme at Hysnes Rehabilitation Centre. These measures include genotype, saliva cortisol, medical-, psychological-, physiological diagnostics and work related factors.
Related aims:
Investigate if multidisciplinary treatment based on acceptance and commitment therapy, contributes to normalisation of cortisol release with regards to a standardized stress test.
See wether individual differences regarding the stress profile can predict return to work in patients with complex symptom disorders.
Investigate genetic risk factors in relation to Return to Work rehabilitation and identify treatment moderators in a multidisciplinary rehabilitation program.
Przegląd badań
Status
Warunki
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Trondheim, Norwegia
- Hysnes Helsefort, St Olavs Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion criteria:
- Age between 18-59 years
- A self defined goal of increasing their work ability and work participation within a period of no more than six months
- They fill the criteria of a complex symptom disorder, or they are diagnosed with a common mental disorder
- A satisfactory level of examination and treatment to participate at Hysnes Rehabilitation Centre
- Sick leave > 8weeks or receiving work ability assessment benefit for any diagnosis, except as stated below.
- On a level of linguistic, physical and mental function required to participate in the rehabilitation
Exclusion criteria:
- Ongoing alcohol/drug abuse
- Ongoing psychosis, ongoing manic episode or suicide risk
- Pregnancy
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Return to work follow-up
Regular contact between the patient and his/her caretaker at the rehabilitation center over a 6 month period, including joint communication between patient, caretaker at the rehabilitation center and stake holders such as social security office, general practitioner and workplace.
|
3 1/2 weeks of Return-to-work rehabilitation followed by 6 months of Return-to-work follow-up
Inne nazwy:
|
|
Aktywny komparator: Standard follow-up
Standard follow-up of the patient after ended rehabilitation by the return-to-work stakeholders, ie. the general practitioner, social security office and the employer.
Limited contact between the caretaker at the rehabilitation center and the patient and stakeholders.
|
3 1/2 weeks of Return-to-work rehabilitation followed by standard follow-up
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Return to work
Ramy czasowe: 1 year after the end of the stay at the rehabilitation center.
|
Differences in cumulative days of sick leave, as reported by the government database "FD-Trygd".
|
1 year after the end of the stay at the rehabilitation center.
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
quality of life
Ramy czasowe: 5 years after the end of the rehabilitation stay
|
Quality of life is assessed by 15D, SF8 and function subscale in SF-36
|
5 years after the end of the rehabilitation stay
|
|
Functional status
Ramy czasowe: 5 year after the end of the rehabilitation stay
|
Functional status will be measured with elements from the Norwegian Function Assessment Scale (Osteras et al., 2007) and the function subscale of SF-36 (Ware Jr & Sherbourne, 1992)
|
5 year after the end of the rehabilitation stay
|
|
level of symptoms (somatic and psychological)
Ramy czasowe: 5 year after the end of the rehabilitation stay,
|
The Hospital Anxiety and Depression Scale (HADS) measure changes in anxiety and depression. Changes regarding physical and mental fatigue are registered through the Chalder Fatigue Questionnaire. Changes in participants subjective experience of pain measured by numerical rating scale (NRS) |
5 year after the end of the rehabilitation stay,
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Petter Borchgrevink, Norwegian University of Science and Technology
Publikacje i pomocne linki
Publikacje ogólne
- Hara KW, Bjorngaard JH, Brage S, Borchgrevink PC, Halsteinli V, Stiles TC, Johnsen R, Woodhouse A. Randomized Controlled Trial of Adding Telephone Follow-Up to an Occupational Rehabilitation Program to Increase Work Participation. J Occup Rehabil. 2018 Jun;28(2):265-278. doi: 10.1007/s10926-017-9711-4.
- Vethe D, Kallestad H, Jacobsen HB, Landro NI, Borchgrevink PC, Stiles TC. The Relationship Between Improvement in Insomnia Severity and Long-Term Outcomes in the Treatment of Chronic Fatigue. Front Psychol. 2018 Sep 21;9:1764. doi: 10.3389/fpsyg.2018.01764. eCollection 2018.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- 2010/2404
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Complex Symptom Disorders
-
Eighth Affiliated Hospital, Sun Yat-sen UniversityJeszcze nie rekrutacjaNiegruźlicze mykobakteryjne zapalenie płuc | Mycobacterium Avium Complex (MAC)
-
Mayo ClinicZakończonyMycobacterium Avium Intracellulare Complex (MAC)Stany Zjednoczone
-
Ottawa Hospital Research InstitutePfizerZakończonyZakażenie wirusem HIV | Infekcja HIV-1 | Mycobacterium Avium Complex (MAC)Kanada
-
Janssen Pharmaceutical K.K.ZakończonyOporna na leczenie Mycobacterium Avium Complex-lung Disease (MAC-LD)Tajwan, Japonia, Korea Południowa